A research team at Kyoto University in Japan has successfully used human induced pluripotent stem cells (iPS cells) to successfully produce "killer T cells" capable of killing cancer cells, making regenerative immune cell therapy a further step toward cancer clinical treatment. White blood cells, as part of the immune system, help the body fight off infectious diseases. T cells with strong cytotoxicity are one kind of white blood cells, and they are the main force in the human body against "bad cells" such as cancer cells, and are also called "killer T cells." Kyoto University issued a press release on November 22, saying that the school's professor He Benhong and others successfully obtained "killer T cells" using human iPS cells, and confirmed its ability to kill leukemia cells in experiments. In addition, the research team also carried out leukemia treatment experiments on immunodeficient mice, confirming that this "killer T cell" is effective. The research team said that there are "killer T cells" in cancer patients, but the amount of "killer T cells" needs to be increased in cancer treatment. Previous "killer T cells" in vitro culture studies have been less successful, and new methods can be obtained. The quality of the "killer T cell" helps to achieve cancer immune cell therapy using regenerative "killer T cells." Processed Frozen Tuna,High Grade Tuna,Bigeye Tuna Can,Tuna Chunk in Oil Can Zhejiang ocean family co.,ltd , https://www.ocean-family.com